Back

Improvement of biomarkers is associated with improved patient quality-of-life measures after heart failure hospitalisation: a sub-study of the Medly-AID randomised controlled trial

18 May 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Artificial intelligence and diagnostic tools Remote Patient Monitoring and Telehealth HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Darshan Brahmbhatt

University Health Network of Toronto, Toronto (Canada)

5 More presentations in this session

Presentation thumbnail
Deep learning in electronic health records to predict incident heart failure by modelling temporal dependencies of antecedent risk factors
Miss S. Mahapatra (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Evaluating a large language model's ability to recommend guideline-directed medical therapy for heart failure: a pilot study
Mr J. Valk (Enschede, NL)
Abstract Slides Video
Presentation thumbnail
Stratification of patients with heart failure referred to cardiology at higher risk of 1-year heart failure admission or mortality by a machine learning algorithm
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Using AI to identify left ventricular ejection fraction from the ECG
Associate Professor M. Ciccarelli (Salerno, IT)
Abstract Slides Video
Presentation thumbnail
Pro-BNP variation as a risk marker of ventricular arrythmias in CRT patients
Doctor L. Sousa Azevedo (Vila Real, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Artificial intelligence and diagnostic tools

The Event

Event poster

Heart Failure 2025

18 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation
thumbnail
Congress Presentation
Real-world monocentric experience of early impact of SGLT2 inhibitors on NT-proBNP levels in heart failure
thumbnail
Congress Presentation
Comparison of NT-ProBNP levels in different groups of chronic heart failure: preliminary data analysis of research

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources